Table 2– Chronic obstructive pulmonary disease (COPD) comorbidity prevalence from studies that included multiple comorbidities in their analysis
First author [ref.]
Divo [46]Vanfleteren [48]Mapel [45]Cazzola [44]Van Manen [49]Schnell [42]
Disease ascertainmentSelf-reportedMeasuredAdministrative databaseAdministrative databaseAdministrative databaseSelf-reported/measured
COPDControlCOPDControlCOPDControlCOPDControl
Subjects n165921320020015 000325 00029042199514 828
Hypertension52.3484536.522.721.460.452.2
Hyperlipidaemia43.53647.641.3
CAD30.292214.515.96.6
Obesity29.02340.333.5
DJD28.72219.554.636.9
Muscle wasting28
Diabetes mellitus21.55486.518.710.57.14.616.312.8
GORD17.7
PAD16.7535.51.7
Depression16.71617137.45.38.74.420.612.5
CRF16.7221.5116.210.5
CHF15.713.52.57.92.012.1
Underweight15.014
Substance abuse13.8
Atrial fibrillation13.0
Anxiety11.9218.63.8
Erectile dysfunction11.7
Gastric/duodenal ulcer11.532177.21.5
CVA10.743.53.13.78.94.5
Pulmonary HTN+CP10.2
OSA10.1
Lung cancer9.11.90.4
Osteoporosis8.43114.810.816.98.5
Hypothyroidism7.0
Breast cancer7.0
AAA6.5
Pulmonary fibrosis6.1
DVT5.1
Anaemia59.36.2
Cardiac arrhythmia129.513.66.9
  • Data are presented as % unless otherwise stated. CAD: coronary artery disease; DJD: degenerative joint disease; GORD: gastro-oesophageal reflux disease; PAD: peripheral artery disease; CRF: chronic renal failure; CHF: congestive heart failure; CVA: cerebrovascular accident; HTN: hypertension; CP: cor pulmonale; OSA: obstructive sleep apnoea; AAA: abdominal aortic aneurism; DVT: deep-venous thrombosis.